The
Corporate Liaison Board will host the 9th Annual CLB Forum at ENDO 08. The CLB Forum highlights the collaboration between industry, academia, and government in approaches to treatment of endocrine disorders. All ENDO attendees are welcome, so don’t miss this quality, CME accredited program.
“Pathways in the Control of
Metabolism: Emerging Links”
Sunday, June 15, 2008, 6:00-9:30pm
The Moscone Center, San Francisco, CA
-
Program Director: Sethu Reddy, MD Merck & Co., Inc.
-
Dr. Christian Weyer, MD, MAS Amylin Pharmaceuticals “Integrated Neurohormonal Control of Body Weight: Implications for Obesity Drug Development”
-
Dr. Jack Yanovski, MD, PhD NICHD/NIH “Pediatric Obesity Syndromes: Beyond Leptin and the Melanocortin 4 Receptor”
-
Dr. Gerard Karsenty, MD, PhD Columbia University Medical Center “Bone Regulation of Glucose Metabolism”
To register for the 2008 CLB Forum, please visit the ENDO 08 Web site. There is no cost to attend this event, but seating reservations are on a first-come, first-served basis. Please contact Nancy Chill at nchill@endo-society.org or 301-941-0203 for more information. We look forward to seeing you in San Francisco!